Figure 3.

Kaplan-Meier estimates of the prognostic impact of KRAS mutation according to histological subtype. Kaplan-Meier analysis of ovarian cancer specific survival according to KRAS mutation status in (A) mucinous, (B) serous and (C) endometrial tumours.

Nodin et al. Diagnostic Pathology 2013 8:106   doi:10.1186/1746-1596-8-106
Download authors' original image